During the past decade, Ospedale Cardinal Massaia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Cardinal Massaia" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials, followed by "IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy" with 3 trials sponsored, "Associazione Qol-one" with 2 trials sponsored, "Fondazione Italiana Sindromi Mielodisplastiche-ETS" with 2 trials sponsored and "Gruppo di Ricerca GISSI" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Cardinal Massaia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Princess Margaret Hospital, Canada" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Cardinal Massaia" are "Myelodysplastic Syndromes" (4 trials), "Atrial Fibrillation" (2 trials), "Adult" (1 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Biventricular Tachycardias" (1 trials). Many other conditions were trialed in "Ospedale Cardinal Massaia" in a lesser frequency.

Most popular intervention types in "Ospedale Cardinal Massaia" are "Drug" (18 trials), "Other" (6 trials), "Procedure" (3 trials), "Device" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "cisplatin" (3 trials), "Eltrombopag/Revolade" (2 trials), "Rituximab" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Cardinal Massaia" are 23 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Cardinal Massaia". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Ospedale Cardinal Massaia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Cardinal Massaia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".